The global cancer cachexia market revenue was valued at USD 2.41 billion in 2023 and is projected to grow from USD 2.48 billion in 2024 to USD 3.43 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.2% during the forecast period. This steady growth reflects the increasing prevalence of cancer worldwide, a higher understanding of cachexia-related complications, and rising...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek